DEC 18 2005

Advantage Begins the Sale of 2005 Tax Credits

Vancouver, December 18, 2005 - BC Advantage Funds (VCC) Ltd ("Advantage") will resume selling is shares through FundSERV (BCA100) on January 19, 2005.... read more

APR 13 2005

Advantage Transfers $5 Million Between Funds

Vancouver, April 13, 2005 - BC Advantage Funds (VCC) Ltd. announced today that its Board of Directors has approved the transfer of $5 million, less applicable issuance costs and historical operating expenditures, from the BC Tech Fund, Advantage’s first technology fund, to the Advantage Venture Fund, its combined technology and life science fund...read more

MAR 14 2005

BC Advantage Funds Portfolio Companies Completes NASDAQ IPO - Advantage Life Sciences Venture Fund NAV increases $9.21 to $30.43

Vancouver, March 14, 2005 - BC Advantage Funds (VCC) Ltd. is pleased to announce that its Life Science Venture Fund portfolio company, Aspreva Pharmaceuticals Corporation , recently completed its initial public offering on the NASDAQ and the TSX stock exchanges, raising Cdn. $112 million through the issuance of 8.2 million of its shares at $13.68 per share... read more

JAN 18 2005

BC Advantage Begins the Sale of 2005 Tax Credits

Vancouver, January 18, 2005 - BC Advantage Funds (VCC) Ltd. will resume selling is shares through FundSERV (BCA100) on January 19, 2005... read more